Friday, January 10, 2020

Element Biosciences Gets $80M For DNA Sequencing

San Diego-based Element Biosciences, which is developing DNA sequencing technology, says it has raised $80M in a Series B funding round. The new funding came from Fidelity Management & Research Company and JS Capital LLC, along with Foresite Capital and Venrock. According to Element Biosciences, the new funds will go towards accelerating the development of its genomic sequencing products. The company has now raised more than $100M in total. Molly He, PhD is CEO and co-founder of Element. Element says it recently moved its headquarters in San Diego into a new, 30,000 square foot facility in University Towne Center, and also is expanding its team there and in the San Francisco Bay Area. More information »